Our system tracks stock market developments with a focus on earnings surprises, price momentum, and analyst expectations.
As of 2026-04-20, Shattuck Labs Inc. (STTK) is trading at $8.2 per share, marking an 8.90% gain on the day amid elevated market interest in the stock. This analysis evaluates key technical levels, recent trading context, sector trends, and potential near-term scenarios for STTK, without making any directional investment recommendations. With no recent earnings data available for the clinical-stage biotechnology firm, price action in recent sessions has been driven primarily by technical trading
Shattuck Labs (STTK) Stock High Frequency (Skyrockets) 2026-04-20 - Max Pain Level
STTK - Stock Analysis
4950 Comments
1942 Likes
1
Anjana
Loyal User
2 hours ago
So much talent packed in one person.
👍 128
Reply
2
Xori
Consistent User
5 hours ago
Wow, did you just level up in real life? 🚀
👍 108
Reply
3
Lakenzi
Elite Member
1 day ago
Expert US stock analyst coverage consensus and rating distribution analysis to understand market sentiment. We aggregate analyst opinions to provide a consensus view of Wall Street expectations for any stock.
👍 267
Reply
4
Jarina
Influential Reader
1 day ago
Execution at its finest.
👍 37
Reply
5
Fiffany
Daily Reader
2 days ago
US stock customer concentration analysis and revenue diversification assessment for business risk evaluation. We identify companies with too much dependency on single customers or concentrated revenue sources.
👍 199
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.